Oncolytics Biotech (ONCY) EPS (Diluted) (2015 - 2026)
Powered by 
Analysis
Oncolytics Biotech (ONCY) EPS (Diluted) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.01 Bn | 193.02 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 179.98 Bn | 176.80 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 131.45 Bn | 123.60 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 82.02 Bn | 74.03 Bn | 3.93 Bn | 12.23 |
| 5 | Argenx Se | 60.35 Bn | 55.16 Bn | 1.37 Bn | 7.15 |
| 6 | Moderna | 53.69 Bn | 48.55 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.11 Bn | 29.80 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 31.93 Bn | 30.64 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.21 Bn | 29.21 Bn | 1.16 Mn | -0.40 |
| 10 | Oncolytics Biotech | 92.81 Mn | 92.81 Mn | - | -0.08 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.08 |
| Sep 30, 2025 | -0.12 |
| Jun 30, 2025 | -0.05 |
| Dec 31, 2024 | -0.07 |
| Sep 30, 2024 | -0.10 |
| Jun 30, 2024 | -0.08 |
| Dec 31, 2023 | -0.04 |
| Sep 30, 2023 | -0.13 |
| Jun 30, 2023 | -0.09 |
| Dec 31, 2022 | -0.11 |
| Sep 30, 2022 | -0.06 |
| Jun 30, 2022 | -0.10 |
| Dec 31, 2021 | -0.11 |
| Sep 30, 2021 | -0.10 |
| Jun 30, 2021 | -0.15 |
| Dec 31, 2020 | -0.18 |
| Sep 30, 2020 | -0.23 |
| Jun 30, 2020 | -0.22 |
| Mar 31, 2020 | 0.02 |
| Sep 30, 2019 | -0.22 |